How can global pharma IT organizations establish enterprise standards and shared platforms while enabling business ownership of outcomes, preserving regional agility, and maintaining compliance? In this ebook, explore a practical approach to modernizing the global pharma IT operating model grounded in three pillars: global platforms, value-stream-aligned technology, and controlled regional execution. Read an outline of the eBook below.

Download the Modernizing the Global Pharma IT Operating Model eBook Here

Balancing Enterprise Standards with Regional Agility

Based on our recent work with clients, we’ve seen global pharmaceutical organizations face increasing pressure to demonstrate measurable value from their technology investments. Large-scale ERP transformations, digital platforms, and AI initiatives are no longer justified as simply “building the foundation.” Executive leadership expects tangible outcomes, including faster time to market, improved operating performance, better access to scalable data insights, and sustained competitive advantage. 

Yet many global pharma companies find themselves at an inflection point. Years of ERP standardization efforts have often resulted in fragmented regional variations. Digital initiatives have been launched with enthusiasm but have struggled to integrate into core business processes. Cross-functional collaboration continues to be stifled and data remains siloed. Governance can swing between over-centralized control and regional workarounds. 

Current State Realities 

Today’s operating model challenges are rarely caused by a lack of technology investment. More often, they emerge when large-scale transformation programs, regional requirements, and business-led digital initiatives move faster than the governance, data foundations, and decision rights needed to support them. Several realities are especially common:

1. Fragmented Global Platforms
2. Siloed Business Alignment
3. Regional Variation and “Standard Drift”

The Target Operating Model 

With these challenges in mind, organizations need a defined pathway for transitioning to an operating model that balances enterprise standards with regional agility. The following considerations outline how global pharma IT can move beyond structural realignment to an operating model built for long-term value:

1. From Projects to Products
2. Establishing Global Platforms
3. Empowering Value Streams
4. Regional Execution with Controlled Variation

Avoiding Common Pitfalls 

Operating model transformation carries several common risks: 

• Over-centralized platform teams can become bottlenecks 
• Value streams can create shadow solutions that weaken enterprise standards 
• Data governance can slow innovation if it’s treated only as a control mechanism 
• Organizations can underinvest in product management or change management capabilities 

A Balanced Path Forward 

Global pharmaceutical organizations need an operating model that establishes enterprise standards while giving regions the flexibility to address local business and regulatory requirements. Global platforms provide a consistent foundation for shared capabilities, and value-stream teams help ensure technology investments deliver measurable business outcomes. When enterprise standards are clear, regions can adapt solutions to local needs without creating unnecessary complexity. That makes it easier to scale successful capabilities across the organization and realize greater value from technology investments over time. 

Download the eBook

Organizations that realize greater value from S/4HANA, enterprise data platforms, and AI initiatives recognize that technology alone is not enough. The operating model must also define clear ownership and support consistent decision-making. The eBook dives deeper into the key points from the outline above, preparing teams to make effective steps towards stronger, modernized IT operating models.